Riley Corbitt v. HHS - Influenza, Guillain-Barre Syndrome (2026)

Riley Corbitt filed a petition for compensation under the National Vaccine Injury Compensation Program on February 10, 2025, alleging Guillain-Barre Syndrome (GBS) as a result of an influenza vaccine administered on October 18, 2022. The petition stated that the vaccine was administered in the United States, that the injury caused residual effects for more than six months, and that no settlements or awards had been made on his behalf.

On June 9, 2026, the Respondent filed a Rule 4(c) report conceding that Petitioner is entitled to compensation. The Respondent concluded that the injury was consistent with SIRVA as defined by the Vaccine Injury Table and that Petitioner met all legal prerequisites for compensation.

Based on the Respondent's concession and the evidence, the Chief Special Master found Petitioner entitled to compensation.